Emotional Freedom Technique (EFT) Applied to Postmenopausal Women on Sleep and Quality of Life

October 1, 2024 updated by: Aslı SİS ÇELİK, Ataturk University

The Effect of Emotional Freedom Technique (EFT) Applied to Postmenopausal Women on Sleep and Quality of Life: A Randomized Controlled Trial

The study will be conducted as a randomized controlled experimental study to determine the effects of the Emotional Freedom Technique (EFT) applied to women in menopause on sleep quality and quality of life.

It will be conducted with 80 women between the ages of 45-64, registered in a family health center in a city in the east of Turkey, who have been in menopause for at least one year and volunteer to participate in the study.

EFT will be applied to the women to be included in the experimental group in the study once a week, a total of four times in a month.

The "Participant Information Form", "Utian Quality of Life Scale" and "Pittsburgh Sleep Quality Scale" prepared by the researchers in line with the literature information will be used in the collection of research data.

Study Overview

Status

Not yet recruiting

Detailed Description

The study will be conducted as a randomized controlled experimental study to determine the effects of the Emotional Freedom Technique (EFT) applied to women in menopause on sleep quality and quality of life.

It will be conducted with 80 women between the ages of 45-64, registered in a family health center in a city in the east of Turkey, who have been in menopause for at least one year and volunteered to participate in the study.

The "simple randomization method" will be selected as the randomization method in the study in order to provide an equal number of samples in two groups. A random number table will be created in a computer environment using the httpp://www.randomizer.org/website for the 80 participants to be sampled, with numbers from 1 to 80 in two groups. It will be decided by tossing a coin to determine which group the groups should be in. The names on the list will be evaluated according to the group corresponding to that order in the table, and accordingly, 40 women will be assigned to the experimental group and 40 women will be assigned to the control group.

EFT will be applied to the women to be included in the experimental group in the study once a week, a total of four times in a month.

When the research is completed, the data of the experimental and control groups (coded as X and Y) will be transferred to the computer environment by a statistician independent of the research and the data will be analyzed and the findings will be reported. Our research is planned to be conducted as a single-blind study in which the statistician will be blinded.

The "Participant Information Form", "Utian Quality of Life Scale" and "Pittsburgh Sleep Quality Scale" prepared by the researchers in line with the literature information will be used in the collection of research data.

Pre-Test Data will be collected between September-October 2024, the interim measurement after the EFT intervention will be made between October-November 2024, and the final measurement will be made between November-December 2024.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Volunteering to participate in the study,
  • Being able to read and write in Turkish,
  • Women between the ages of 45-64 who have not had menstrual bleeding for at least one year (women under the age of 65 who have entered natural menopause),
  • Not being diagnosed with a psychiatric disease,
  • Not using Hormone Replacement Therapy (HRT),
  • Not using antidepressants, antihistamines, benzodiazepines, hypnotics and narcotics, etc.,
  • Not using any complementary and alternative medicine (such as Reiki, phytoestrogens, acupressure).
  • Scoring '5 and above' on the Pittsburgh Sleep Quality Scale

Exclusion Criteria:

  • Starting to use Hormone Replacement Therapy after starting the study,
  • Starting to use antidepressants, antihistamines, benzodiazepines, hypnotics and narcotics, etc.,
  • Starting to use any complementary and alternative medicine method,
  • Voluntarily leaving the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
no intervention will be applied to the control group
Experimental: Experimental Group
EFT will be applied to the women to be included in the experimental group in the study once a week, a total of four times in a month.
EFT basically involves serial tapping on acupuncture points, no needles are used, there is no invasive procedure, there are affirmation suggestions, it is an easy, painless, simple but effective method that can be done in minutes. It is realized by applying kinetic energy to certain meridians on the head and chest with the fingertips. The points where the tapping is done are the end points of the meridians in the body. They are located symmetrically on both sides of the body. Since these points are close to the skin surface, they are points that are more easily reached than the deeper buried parts of the meridians. While applying pressure with the fingertips, the individual needs to focus on the problem that bothers him/her. Another thing that needs to be done at the same time is for the person to make positive suggestions to himself/herself vocally.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life levels during menopause
Time Frame: 1 month
The difference between the Utian Quality of Life Scale pretest and posttest mean scores of women in both groups. The lowest score that can be obtained from the scale is 23, and the highest score is 115. An increase in the scale score indicates an increase in the quality of life.
1 month
Quality of sleep levels during menopause
Time Frame: 1 month
The difference between the Utian Quality of Life Scale pretest and posttest mean scores of women in both groups. The sleep quality of individuals whose total scale score is 5 points or less is considered "good"; the sleep quality of individuals whose score is above 5 points is considered "bad".
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Aslı SİS ÇELİK, Ataturk University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2024

Primary Completion (Estimated)

October 1, 2024

Study Completion (Estimated)

November 1, 2024

Study Registration Dates

First Submitted

August 28, 2024

First Submitted That Met QC Criteria

August 28, 2024

First Posted (Actual)

August 29, 2024

Study Record Updates

Last Update Posted (Actual)

October 2, 2024

Last Update Submitted That Met QC Criteria

October 1, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • aslı12

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Menopause Related Conditions

Clinical Trials on Emotional Freedom Technique

Subscribe